Strive Metrics: Analysis Details
Author: Strive Health67% increase in optimal starts
Compares the rate of optimal starts for patients enrolled in the Strive program to that of unenrolled patients across all active Strive markets. Optimal starts is defined as a planned start of renal replacement therapy by receiving a preemptive kidney transplant, initiating home dialysis, or initiating in-center hemodialysis via AVF or AVG.
36% reduction in 30-day hospital readmissions
Compares the 30-day hospital readmission rate for patients enrolled in a Strive health system ACO program to a three-year historical benchmark.
49% reduction in hospitalizations among high-risk patients
Compares the all-cause hospitalization rate for Complex patients who are engaged in the Strive program to a historical benchmark. “Complex” is the highest-risk tier in Strive’s composite risk scoring model, which uses factors such as the Charlson Comorbidity Index, CDC Social Vulnerability Index, and prior hospital visits
47% greater Peritoneal Dialysis (PD) Start Rate compared to national average
Time Period: 1/1/2021 – 5/1/2022. Patients have been Optimal Start Candidates for 3 months, are plan eligible and enrolled in Stive programs at the time of dialysis transition and have known transition modality. Compared to USRDS, 2021 Report Highlights: https://adr.usrds.org/2021/end-stage-renal-disease/1-incidence-prevalence-patient-characteristics-and-treatment-modalities
52% greater Home Modality (Home Hemo + PD) Start Rate compared to the national average
Time Period: 1/1/2021 – 5/1/2022. Patients have been Optimal Start Candidates for 3 months, are plan eligible and enrolled in Stive programs at the time of dialysis transition and have known transition modality. Compared to USRDS, 2021 Report Highlights: https://adr.usrds.org/2021/end-stage-renal-disease/1-incidence-prevalence-patient-characteristics-and-treatment-modalities